Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Browse Articles

Search Articles 

Publication Title Author Date Volume Abstract
DIAJ Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies Zheng Su 2011 45(06) View Abstract
DIAJ Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies 2011 45(06) View Abstract
DIAJ Review of: Fundamentals of US Regulatory Affairs, 7th ed. Edward Tabor 2011 45(06) View Abstract
DIAJ Certification for the Medical Science Liaison: An Idea Whose Time Has come---or Not Kenneth L Massey,Jane Chin,Jimmy Thomas Black 2011 45(06) View Abstract
DIAJ Medical Information Services in the Age of Social Media and New Customer Channels Lesley S. Fierro,Poonam A. Bordoloi,Michelle Clausen,Krupa Paranjpe,Andrew Gazo 2011 45(06) View Abstract
DIAJ Clinically Important Effects in New Drug Development Satoshi Hashigaki,Kanae Togo,Takashi Moriya,Keiji Imai 2011 45(06) View Abstract
DIAJ Assessment of Electronic Drug Information Research Availability in Alabama Pharmacies Michael G Kendrach,Bob Schrimsher,Maisha Kelly Freeman 2011 45(06) View Abstract
DIAJ Content Analysis of Off-label Drug Use: Reporting Print Media Coverage David A. Holdford,Avani D Joshi 2011 45(06) View Abstract
DIAJ Failure to Communicate: Medication Guide or Memory ? Louis A Morris,Morris S Whitcup 2011 45(06) View Abstract
DIAJ Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information Service Robert Fuentes,Michael Hoopes,Gregory M Susla,Pamela D Allen 2011 45(06) View Abstract
DIAJ Validation of Decision-enabling Tools: Showing That the Model Is Useful Stig J Wiklund 2011 45(06) View Abstract
DIAJ A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making Andreas I. Sashegyi 2011 45(06) View Abstract
DIAJ Letter to the Editor: Selection of the Time Points for a Thorough QTc Study Norman Stockbridge,Joanne Zhang 2011 45(06) View Abstract
DIAJ A Longitudinal Model and Graphic for Benefit-risk Analysis, With Case Study Jonathan D. Norton 2011 45(06) View Abstract
DIAJ Platelet Aggregation Quality Control in a Multicenter Phase 2 Clinical Trial James McRedmond 2011 45(06) View Abstract
DIAJ Ten-year Experience of the Evaluation of Ethnic Sensitivity Data Chia-Ling Hsiao 2011 45(06) View Abstract
DIAJ Letter to the Editor 2011 45(06) View Abstract
DIAJ Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth Peter J. Pitts 2011 45(06) View Abstract
DIAJ Preparing for a Safety Inspection Steve Jolley 2011 45(06) View Abstract
DIAJ Associate Editor's Commentary: The Danger of Shorting Drug Shortages Peter J. Pitts 2011 45(06) View Abstract
DIAJ Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk- Benefit Assessment John Doyle 2011 45(06) View Abstract
DIAJ Editor's Commentary: A Time for Reflection and Anticipation Rick Turner 2011 45(06) View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Nov 01, 2012 Issue 9 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Aug 01, 2012 Issue 8 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) May 01, 2012 Issue 7 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Feb 01, 2012 Issue 6 View Abstract
CHNNEWS Global Pharmaceutical Forum (In Chinese) Nov 01, 2011 Issue 5 View Abstract
GF Global Forum Oct 01, 2013 13(05) View Abstract
GF Global Forum Aug 01, 2013 13(04) View Abstract
GF Global Forum Jun 01, 2013 13(03) View Abstract
GF Global Forum Apr 01, 2013 13(02) View Abstract
GF Global Forum Feb 01, 2013 13(01) View Abstract
GF Global Forum Dec 01, 2012 12(06) View Abstract
GF Global Forum Oct 01, 2012 12(05) View Abstract
GF Global Forum Aug 01, 2012 12(04) View Abstract
GF Global Forum Jun 01, 2012 12(03) View Abstract
GF Global Forum Apr 01, 2012 12(02) View Abstract
GF Global Forum Feb 01, 2012 12(01) View Abstract
GF Global Forum Dec 01, 2011 11(06) View Abstract